11 results on '"Varah, Nina"'
Search Results
2. Correction to: Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes
- Author
-
Monaco, Cynthia M. F., Hughes, Meghan C., Ramos, Sofhia V., Varah, Nina E., Lamberz, Christian, Rahman, Fasih A., McGlory, Chris, Tarnopolsky, Mark A., Krause, Matthew P., Laham, Robert, Hawke, Thomas J., and Perry, Christopher G. R.
- Published
- 2020
- Full Text
- View/download PDF
3. Impaired Cold Stimulated Supraclavicular Brown Adipose Tissue Activity in Young Boys with Obesity
- Author
-
Ahmed, Basma A., primary, Varah, Nina, primary, Ong, Frank J., primary, Blondin, Denis P., primary, Gunn, Elizabeth, primary, Konyer, Norman B., primary, Singh, Nina P., primary, Noseworthy, Michael D., primary, Haman, Francois, primary, Carpentier, Andre C., primary, Punthakee, Zubin, primary, Steinberg, Gregory R., primary, and Morrison, Katherine M., primary
- Published
- 2022
- Full Text
- View/download PDF
4. Linking Brown Adipose Tissue and NAFLD By Metabolomics in Adults and Children
- Author
-
Varah, Nina, Morrison, Katherine, and Medical Sciences
- Subjects
Non-Alcoholic Fatty Liver Disease ,Brown Adipose Tissue ,Metabolomics ,Adults ,Children ,Magnetic Resonance Imaging - Abstract
Nina Varah MSc Thesis BACKGROUND: Brown adipose tissue (BAT) has emerged as an attractive target to address the dramatic rise in obesity and non-alcoholic fatty liver disease (NAFLD) in adults and children due to its ability to clear lipids through thermogenesis when activated with cold stimulation. Cross-sectional studies have identified an inverse relationship between BAT and NAFLD in adults, although no linking mechanism or relevance in children is known. Metabolomics provides a non-invasive platform to investigate BAT physiology and its relationship with hepatic fat in an effort to identify potential targets for further investigation. PROJECT OBJECTIVES: 1) To explore the associations between the plasma metabolome and BAT in adults and children. 2) To explore the associations between the plasma metabolome and hepatic fat in adults and children. 3) To identify metabolites associated with both BAT and hepatic fat as potential linking mechanisms for further study. METHODOLOGY: We recruited 63 male and female adults aged 18 to 57 years and 25 healthy male children aged 8 to 10 years into this cross-sectional study. Study participants underwent blood work, body composition measurement (dual energy X-ray absorptiometry; DXA) and magnetic resonance imaging (MRI) - proton density fat fraction (PDFF) measurements of whole liver hepatic fat, pre- and post-cold supraclavicular fat. BAT activity was calculated as the percent change between post and pre-cold BAT PDFF with the cold stimulus consisting of a water-perfused suit maintained at 18°C for 3-hours (adult) or 1-hour (pediatric). Targeted liquid-chromatography/mass spectrometry metabolomics of 102 metabolites was conducted on fasted plasma and multivariate linear regression with multiple testing correction was used to examine metabolite predictors of BAT measures and hepatic fat. RESULTS: In the adult cohort (n=63, median age 25.9 years, median body mass index (BMI) 25.4 kg/m2), five metabolites were associated with baseline BAT lipid content, where an elevated lipid content may indicate a whiter adipose tissue-like phenotype. Aconitate and creatine commonly predict increased baseline BAT lipid content (β=0.420, P=0.001 and β=0.408, P=0.001, respectively), and reduced BAT activity (β=-0.462, P=0.002 and (β=-0.402, P=0.002, respectively). Alanine and two acyl-carnitines also predicted reduced BAT activity. Glutamic acid was similarly related to higher baseline BAT (β=0.480, P
- Published
- 2020
5. Impaired Cold-Stimulated Supraclavicular Brown Adipose Tissue Activity in Young Boys With Obesity.
- Author
-
Ahmed, Basma A., Varah, Nina, Ong, Frank J., Blondin, Denis P., Gunn, Elizabeth, Konyer, Norman B., Singh, Nina P., Noseworthy, Michael D., Haman, Francois, Carpentier, Andre C., Punthakee, Zubin, Steinberg, Gregory R., and Morrison, Katherine M.
- Subjects
- *
OBESITY , *CHILDHOOD obesity , *ANTHROPOMETRY , *CROSS-sectional method , *MAGNETIC resonance imaging , *PROTONS , *RESEARCH funding , *ADIPOSE tissues - Abstract
Childhood obesity is a growing worldwide problem. In adults, lower cold-induced brown adipose tissue (BAT) activity is linked to obesity and metabolic dysfunction; this relationship remains uncertain in children. In this cross-sectional study, we compared cold-induced supraclavicular (SCV) BAT activity (percent change in proton density fat fraction [PDFF]) within the SCV region after 1 h of whole-body cold exposure (18°C), using MRI in 26 boys aged 8-10 years: 13 with normal BMI and 13 with overweight/obesity. Anthropometry, body composition, hepatic fat, visceral adipose tissue (VAT), and pre- and postcold PDFF of the subcutaneous adipose tissue (SAT) in the posterior neck region and the abdomen were measured. Boys with overweight/obesity had lower cold-induced percent decline in SCV PDFF compared with those with normal BMI (1.6 ± 0.8 vs. 4.7 ± 1.2%, P = 0.044). SCV PDFF declined significantly in boys with normal BMI (2.7 ± 0.7%, P = 0.003) but not in boys with overweight/obesity (1.1 ± 0.5%, P = 0.053). No cold-induced changes in the PDFF of either neck SAT (-0.89 ± 0.7%, P = 0.250, vs. 0.37 ± 0.3%, P = 0.230) or abdominal SAT (-0.39 ± 0.5%, P = 0.409, and 0.25 ± 0.2%, P = 0.139, for normal BMI and overweight/obesity groups, respectively) were seen. The cold-induced percent decline in SCV PDFF was inversely related to BMI (r = -0.39, P = 0.047), waist circumference (r = -0.48, P = 0.014), and VAT (r = -0.47, P = 0.014). Thus, in young boys, as in adults, BAT activity is lower in those with overweight/obesity, suggesting that restoring activity may be important for improving metabolic health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H 2 O 2 emission during impaired oxidative phosphorylation
- Author
-
Hughes, Meghan C., primary, Ramos, Sofhia V., additional, Turnbull, Patrick C., additional, Rebalka, Irena A., additional, Cao, Andrew, additional, Monaco, Cynthia M.F., additional, Varah, Nina E., additional, Edgett, Brittany A., additional, Huber, Jason S., additional, Tadi, Peyman, additional, Delfinis, Luca J., additional, Schlattner, U., additional, Simpson, Jeremy A., additional, Hawke, Thomas J., additional, and Perry, Christopher G.R., additional
- Published
- 2019
- Full Text
- View/download PDF
7. Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration
- Author
-
Rebalka, Irena A., primary, Monaco, Cynthia M. F., additional, Varah, Nina E., additional, Berger, Thorsten, additional, D’souza, Donna M., additional, Zhou, Sarah, additional, Mak, Tak W., additional, and Hawke, Thomas J., additional
- Published
- 2018
- Full Text
- View/download PDF
8. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylation.
- Author
-
Hughes, Meghan C., Ramos, Sofhia V., Turnbull, Patrick C., Rebalka, Irena A., Cao, Andrew, Monaco, Cynthia M.F., Varah, Nina E., Edgett, Brittany A., Huber, Jason S., Tadi, Peyman, Delfinis, Luca J., Schlattner, U., Simpson, Jeremy A., Hawke, Thomas J., and Perry, Christopher G.R.
- Subjects
DUCHENNE muscular dystrophy ,OXIDATIVE phosphorylation ,MUSCLE diseases ,RESPIRATORY muscles ,MUSCLE weakness ,ADENOSINE diphosphate - Abstract
Background: Muscle wasting and weakness in Duchenne muscular dystrophy (DMD) causes severe locomotor limitations and early death due in part to respiratory muscle failure. Given that current clinical practice focuses on treating secondary complications in this genetic disease, there is a clear need to identify additional contributions in the aetiology of this myopathy for knowledge‐guided therapy development. Here, we address the unresolved question of whether the complex impairments observed in DMD are linked to elevated mitochondrial H2O2 emission in conjunction with impaired oxidative phosphorylation. This study performed a systematic evaluation of the nature and degree of mitochondrial‐derived H2O2 emission and mitochondrial oxidative dysfunction in a mouse model of DMD by designing in vitro bioenergetic assessments that attempt to mimic in vivo conditions known to be critical for the regulation of mitochondrial bioenergetics. Methods: Mitochondrial bioenergetics were compared with functional and histopathological indices of myopathy early in DMD (4 weeks) in D2.B10‐DMDmdx/2J mice (D2.mdx)—a model that demonstrates severe muscle weakness. Adenosine diphosphate's (ADP's) central effect of attenuating H2O2 emission while stimulating respiration was compared under two models of mitochondrial‐cytoplasmic phosphate exchange (creatine independent and dependent) in muscles that stained positive for membrane damage (diaphragm, quadriceps, and white gastrocnemius). Results: Pathway‐specific analyses revealed that Complex I‐supported maximal H2O2 emission was elevated concurrent with a reduced ability of ADP to attenuate emission during respiration in all three muscles (mH2O2: +17 to +197% in D2.mdx vs. wild type). This was associated with an impaired ability of ADP to stimulate respiration at sub‐maximal and maximal kinetics (−17 to −72% in D2.mdx vs. wild type), as well as a loss of creatine‐dependent mitochondrial phosphate shuttling in diaphragm and quadriceps. These changes largely occurred independent of mitochondrial density or abundance of respiratory chain complexes, except for quadriceps. This muscle was also the only one exhibiting decreased calcium retention capacity, which indicates increased sensitivity to calcium‐induced permeability transition pore opening. Increased H2O2 emission was accompanied by a compensatory increase in total glutathione, while oxidative stress markers were unchanged. Mitochondrial bioenergetic dysfunctions were associated with induction of mitochondrial‐linked caspase 9, necrosis, and markers of atrophy in some muscles as well as reduced hindlimb torque and reduced respiratory muscle function. Conclusions: These results provide evidence that Complex I dysfunction and loss of central respiratory control by ADP and creatine cause elevated oxidant generation during impaired oxidative phosphorylation. These dysfunctions may contribute to early stage disease pathophysiology and support the growing notion that mitochondria are a potential therapeutic target in this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Abstract 16525: Evaluating The Rate Of Coumadin Prescription In The Era Of Direct Oral Anticoagulants
- Author
-
Shamiss, Yana, Alipour, Pouria, Azizi, Zahra, Tohidi, Hadi, Jansen, Claire, Shusterman, Alexander, Varah, Nina, Donegan, Sarah, Nath, Sereena, Avoulov, Alona, Tamjidi, Sara, Lightstone, Hodaya, Morris, Stacey, and Khaykin, Yaariv
- Abstract
Introduction:Clinical, health economic and quality of life data supports the Direct Oral Anticoagulants (DOAC) over warfarin in patients at risk for thromboembolic events in the setting of non-valvulvar atrial fibrillation (AF). We sought to evaluate the rate and reasons for ongoing use of warfarin in this population.Methods:Baseline, follow up, medication reconciliation and insurance status data for all patients treated with warfarin at a large AF clinic were collected for this analysis. Contraindication to DOAC use were noted for all patients in the cohort. History of cardiovascular, renal, and hepatic disease, as well as the CHA2DS2-VASc score was obtained for all patients. Canadian Cardiovascular Society 2018 guidelines was used to assess treatment appropriateness.Results:553 patients treated with warfarin at the time of data collection (August 2018, Mean age: 76.0?9.6 years, 52% Male, Mean CHA2DS2-VASc score: 3.5?1.3) were identified and included in this analysis. Of those on warfarin 16% (88) did not have private insurance and were under the age of 65 (no public coverage), 18% (101) had a mechanical valve, 13% (74) had severe renal impairment, 3.4% (19) had a prior major bleeding episode, 10 of which occurred while patient was treated with a DOAC. Remaining 271 (49%) were eligible for treatment with a DOAC.Conclusion:Half of the patients seen at a large atrial fibrillation clinic treated with warfarin as of 2018 had no contraindications to a DOAC, but for reasons related to medication coverage, patient and physician comfort remain on warfarin. This population may derive further benefit from appropriate conversion to a DOAC.
- Published
- 2019
- Full Text
- View/download PDF
10. Abstract 16535: EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINIC
- Author
-
Shamiss, Yana, Alipour, Pouria, Azizi, Zahra, Tohidi, Hadi, Shusterman, Alexander, Lightstone, Hodaya, Morris, Stacey, Nath, Sereena, Varah, Nina, Donegan, Sarah, Avoulov, Alona, Jansen, Claire, Tamjidi, Sara, and Khaykin, Yaariv
- Abstract
Introduction:Evidence supports utilization of Direct Oral Anticoagulants (DOAC) in patients at risk for stroke or thromboembolic events in the setting of non-valvular atrial fibrillation (AF) . Unfortunately, a number of patients may be at risk of adverse outcomes related to under treatment. We sought to describe DOAC prescribing patterns at a large AF clinic and understand the rate and reasons for subclinical DOAC dosing in these patients.Methods:Baseline, and follow up data for all patients on low dose Rivaroxaban (R) (15mg OD), Dabigatran (D) (110mg BiD), and Apixaban(A) (2.5mg BiD) was collected for analysis. Patients were then stratified into one of 3 groups based on the DOAC prescribed. History of cardiovascular, renal, and hepatic disease, as well as the HAS-BLED score was obtained for all patients.Results:629 patients were included in this analysis (Mean age: 82.3?7.6 years, 68.9% Male, A: 152, D: 242, R: 210). Average HAS-BLED score was 2.4 (A: 2.5?1.1, D: 2.2?0.8, R: 2.7?1.0) for all patients. Overall 63% (A: 52%, D:75%, R: 58%) were appropriately prescribed the lower dose of DOAC. Patients who were undertreated had an average HAS-BLED score of 2.5 (A: 2.5?0.9, D: 2?0.8, R: 2.5?1.0) vs. 2.4 (A: 2.5?1.0, D: 2.3?1.0, R: 2.9?1.0) P=0.16, for patients appropriately receiving the lower dose. Of the undertreated patients 12 had prior history of stroke (A: 3, D: 3, R: 6). Reasons for dose reduction included concomitant treatment with antiplatelet agents in 33 patients (A: 5, D: 7, R: 21), age greater than 80 as a sole factor in 93 patients (A: 56, D: 0, R: 37) and elevated creatinine (Scr>130umol/L) as a sole factor in 21 patients (A: 4, D: 4, R: 13). Of the patients on reduced dose of DOAC, those on Rivaroxaban were the most likely to be undertreated (P=0.03). The most significant factor for prescription of lower DOAC dose was age greater than 80 years (P=0.001).Conclusion:A significant number of patients with non-valvular AF who have clinical indications for oral anticoagulation therapy are undertreated with DOACs. Age greater than 80 appears to be the main reason for undertreatment. This pattern is not driven by objectively higher risk of bleeding according to the patient?s HAS-BLED score.
- Published
- 2019
- Full Text
- View/download PDF
11. Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration.
- Author
-
Rebalka IA, Monaco CMF, Varah NE, Berger T, D'souza DM, Zhou S, Mak TW, and Hawke TJ
- Subjects
- Adipokines genetics, Adipokines metabolism, Adipose Tissue metabolism, Adipose Tissue pathology, Animals, Gene Expression Regulation genetics, Humans, Lipocalin-2 metabolism, Matrix Metalloproteinase 9 metabolism, Mice, Mice, Knockout, Muscle, Skeletal metabolism, Myoblasts metabolism, Myoblasts pathology, Regeneration genetics, Regeneration physiology, Satellite Cells, Skeletal Muscle metabolism, Satellite Cells, Skeletal Muscle pathology, Wound Healing genetics, Lipocalin-2 genetics, Matrix Metalloproteinase 9 genetics, Muscle, Skeletal growth & development
- Abstract
Lipocalin-2 (LCN2) is an adipokine previously described for its contribution to numerous processes, including innate immunity and energy metabolism. LCN2 has also been demonstrated to be an extracellular matrix (ECM) regulator through its association with the ECM protease matrix metalloproteinase-9 (MMP-9). With the global rise in obesity and the associated comorbidities related to increasing adiposity, it is imperative to gain an understanding of the cross talk between adipose tissue and other metabolic tissues, such as skeletal muscle. Given the function of LCN2 on the ECM in other tissues and the importance of matrix remodeling in skeletal muscle regeneration, we examined the localization and expression of LCN2 in uninjured and regenerating wild-type skeletal muscle and assessed the impact of LCN2 deletion (LCN2
-/- ) on skeletal muscle repair following cardiotoxin injury. Though LCN2 was minimally present in uninjured skeletal muscle, its expression was increased significantly at 1 and 2 days postinjury, with expression present in Pax7-positive satellite cells. Although satellite cell content was unchanged, the ability of quiescent satellite cells to become activated was significantly impaired in LCN2-/- skeletal muscles. Skeletal muscle regeneration was also significantly compromised as evidenced by decreased embryonic myosin heavy chain expression and smaller regenerating myofiber areas. Consistent with a role for LCN2 in MMP-9 regulation, regenerating muscle also displayed a significant increase in fibrosis and lower ( P = 0.07) MMP-9 activity in LCN2-/- mice at 2 days postinjury. These data highlight a novel role for LCN2 in muscle regeneration and suggest that changes in adipokine expression can significantly impact skeletal muscle repair.- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.